Series A rounds in the last 90 days

359 startups raised $13.7B in total at Series A in the last 90 days. Largest rounds first.

1. Atlas Atomics (atlasatomics.com) — Series A · $400M. Investors: Andreessen Horowitz, General Catalyst
   Atlas Atomics is developing improved heavy-water reactor technology that does not rely on enriched uranium for energy production.
2. Lila Sciences (lila.ai) — Series A · $350M · Boston, US. Investors: ARK Venture Fund, Abu Dhabi Investment Authority, Abundance Membership, Altitude Life Science Ventures
   Lila Sciences is building a scientific platform and autonomous labs for life, chemical, and materials sciences for researchers and industries in those fields.
3. Ricursive Intelligence (ricursiveintelligence.com) — Series A · $335M · Palo Alto, US. Investors: Lightspeed Venture Partners, Nvidia, Sequoia Capital
   Ricursive Intelligence is building a frontier AI lab for developing advanced AI technologies.
4. barq (barq.com) — Series A · $329.5M · Riyadh, SA. Investors: M20 Fund, Noon Investments, Sohar International Bank
   barq is building a digital payments platform for users in Saudi Arabia and beyond.
5. Barq (web.barq.app) — Series A · $329.5M. Investors: NULL
   Barq is building a financial technology platform for consumers to access digital payment services.
6. Onodrim Industries (onodrimindustries.com) — Series A · $300M · Amsterdam, NL. Investors: 137 Ventures, 8090, Altimeter Capital, Expeditions
   Onodrim Industries is building solutions for defence and industrial technologies to accelerate advancements in Europe.
7. Anew Labs (anewbt.com) — Series A · $290M · Shanghai, CN. Investors: 5Y Capital, Boyu Capital, Gaorong Ventures, HSG
   Anew Labs is building a biotech company focusing on AI-driven drug discovery for healthcare applications.
8. OBN Capital (obncapital.net) — Series A · $250M · São Paulo, BR
   OBN Capital is building a micro private-equity hedge fund focused on raising capital in Western currencies to invest in operating businesses and hard assets in emerging economies.
9. Aiolos Bio (theorg.com) — Series A · $245M
   Aiolos Bio is building novel therapies based on TSLP antibodies for patients suffering from immune-mediated diseases.
10. Euclyd (euclyd.ai) — Series A · $230.8M · Eindhoven, NL. Investors: Samsung Electronics, Scaleup Europe Fund, Somerset Capital Partners
    Euclyd is building advanced chip solutions for technology industries.
11. EUCLYD (euclyd.ai) — Series A · $230.8M · Eindhoven, NL. Investors: Innovation Industries, Samsung, Scaleup Europe Fund, Somerset Capital Partners
    EUCLYD is developing an AI infrastructure platform spanning specialized compute, memory architecture, and full data-center systems for enterprise and hyperscale customers.
12. Solstice Oncology (solsticeoncology.com) — Series A · $225M · Cambridge, US
    Solstice Oncology is building a clinical-stage immuno-oncology company focused on treating cancer earlier, in the neoadjuvant setting.
13. Teamshares (teamshares.com) — Series A · $225M · New York, US. Investors: T. Rowe Price
    Teamshares is a tech-enabled acquiror of high-quality businesses, intending to be a permanent home for businesses.
14. Warp Sciences (warp.xyz) — Series A · $215M · San Francisco Bay Area, US. Investors: IVP, Lightspeed Venture Partners, Lux Capital, Mayfield
    Warp Sciences is building U.S.-based laboratory infrastructure that combines artificial intelligence, robotics and chemistry to help pharmaceutical and biotechnology companies make and test molecules.
15. Axiom Math (axiommath.ai) — Series A · $200M · Stanford, US. Investors: Menlo Ventures
    Axiom Math is building an AI mathematician for solving complex mathematical problems.
16. doubleAI (doubleai.com) — Series A · $200M. Investors: BRM, Bessemer Venture Partners, Dell Technologies Capital, Greenfield Partners
    doubleAI is building AI models that optimize software execution to reduce computing costs for its customers.
17. Eka Robotics (ekarobotics.com) — Series A · $150M · Cambridge, US. Investors: Andreessen Horowitz, Bison Ventures, E14 Fund, F-Prime Capital
    Eka Robotics is building a vision-force-action model to develop dexterous robots for handling unfamiliar objects and tasks.
18. Emerald AI (emeraldai.co) — Series A · $150M · Phoenix, US. Investors: Amplo, CRV, NVentures, Neotribe Ventures
    Emerald AI is building a software platform that orchestrates AI workloads in real-time for data centers to dynamically adjust energy consumption and support grid stability.
19. Hertha Metals (herthametals.com) — Series A · $133.7M · Conroe, US. Investors: Doerr Capital
    Hertha Metals is building a facility to produce high-purity iron for domestic rare-earth magnet manufacturing.
20. BrainChild Bio (brainchildbio.com) — Series A · $116M
    BrainChild Bio is building innovative therapies for targeting CNS tumors, starting with children's brainstems.
21. Neurophos (neurophos.com) — Series A · $110M · Austin, US
    The Duke U.-based photonics startup raised $110M to develop optical processors enhancing AI efficiency.
22. Velaura AI (velaura.ai) — Series A · $110M · Silicon Valley, US. Investors: Capricorn Partners, MARA Holdings, Maverick Silicon, Mayfield
    Velaura AI is building lower-power computing technology for AI data centers and physical-AI systems for operators and intelligent machines.
23. Habitat (evolvedhabitat.com) — Series A · $104M · Changzhou, CN. Investors: Changzhou Xinbei District Science and Technology Innovation Fund
    Habitat is building a lifestyle-intelligence firm applying automotive-style product development to integrated smart homes.
24. BioGeometry (biogeometry.com) — Series A · $100M. Investors: CDB Technology Venture Capital, China Life Capital, Fortune Capital, Guofang Ventures
    BioGeometry is building AI-native biopharmaceutical technologies for the development of innovative life sciences solutions.
25. Foundry Robotics (foundryrobotics.ai) — Series A · $100M · Emeryville, US
    Foundry Robotics is building an autonomous factory to revitalize U.S. manufacturing and create more capacity to build and scale critical product assembly for defense and commercial sectors.
26. Maven Robotics (mavenrobotics.com) — Series A · $100M · Santa Clara, US. Investors: LocalGlobe, RoboStrategy, Vine Ventures, XTX Ventures
    Maven Robotics is building intelligent robotics for logistics and manufacturing to create the world's first general-purpose robotics system for industrial work.
27. Neo Security (neo.ai) — Series A · $100M · Boston, US. Investors: Bessemer Venture Partners
    Neo Security is building an endpoint security platform designed for AI agents to give enterprises real visibility and control over their agents.
28. Startup Studio (startupstudiovc.com) — Series A · $100M
    Startup Studio is building infrastructure for real-world robotics and autonomous systems.
29. Universal Quantum (universalquantum.com) — Series A · $100M · Hamburg, GB. Investors: Artal Capital, DCVC, EDBI, EdenBase
    Universal Quantum is building a modular trapped-ion architecture for quantum computing.
30. Estuary Biotherapeutics (estuarybio.com) — Series A · $93M · California, US. Investors: 4BIO Capital, Deep Track Capital, RA Capital Management
    Estuary Biotherapeutics is building gene therapies for treating kidney disease.
31. Alethio Therapeutics (alethiotherapeutics.com) — Series A · $90M · Oxford, GB. Investors: Cancer Research Horizons, Oxford Science Enterprises, RA Capital Management, Sofinnova Partners
    Alethio Therapeutics is building treatments for rare blood cancers, specifically targeting myeloproliferative neoplasms for patients who are underserved by existing therapies.
32. Link Cell Therapies (linkcelltx.com) — Series A · $90M · South San Francisco, US. Investors: Bristol Myers Squibb, Johnson & Johnson Innovation – JJDC, Inc., Kyowa Kirin, MD Anderson Cancer Focus Fund
    Link Cell Therapies is building next-generation CAR-T therapeutics for solid and liquid cancers.
33. Setara Biosciences (setarabiosciences.com) — Series A · $90M · San Diego, US
    Setara Biosciences is building precision medicines for rare genetic diseases and related expansion indications.
34. Volantis (volantis.com) — Series A · $88M · San Mateo, US. Investors: Abstract Ventures, John Doerr, Lachy Groom, Sam Altman
    Volantis is building a photonic compute architecture for high-performance computing systems.
35. Ellipsis Health (ellipsishealth.com) — Series A · $85M · San Francisco, US. Investors: 25madison, CVS Health Ventures, General Catalyst
    Ellipsis Health is building a voice artificial intelligence platform to enhance mental health care delivery for patients experiencing clinical depression and anxiety.
36. Go.AI (go.ai) — Series A · $85M · Chicago, US. Investors: GFT Ventures, LAUNCH, Updata Partners
    Go.AI is building a powerful AI platform for organizations that prioritize data security and control.
37. Project Omega (projectomega.com) — Series A · $80M · Newport, US. Investors: 645 Ventures, B Capital, Decisive Point, Essential Capital
    Project Omega is building betavoltaic batteries for remote power solutions and developing nuclear-waste recycling processes.
38. Breye Therapeutics (breye.com) — Series A · $75.8M. Investors: Catalyze Capital, EIFO, Innovestor Life Science Fund, Ljungström family office
    Breye Therapeutics is building oral therapeutics for the early treatment of retinal diseases.
39. HubX (hubx.co) — Series A · $75M · Izmir, TR. Investors: Point72 Ventures
    HubX is building generative AI consumer applications for users looking for enhanced app experiences.
40. XDOF (xdof.ai) — Series A · $70M. Investors: Thrive Capital, Andreessen Horowitz
    XDOF is building a data business that collects, sorts, and processes real-world interaction data for robots.
41. RegCell (regcellbio.com) — Series A · $66M · Emeryville, US. Investors: Alumni Ventures, Fast Track Initiative, Global Brain, Kyoto iCAP
    RegCell is a biotechnology company developing first-in-class therapies to restore immune tolerance for patients with autoimmune diseases.
42. Mueon Corporation (mueon.com) — Series A · $65M · Portland, US. Investors: Defined Capital, Geodesic Alliances Fund, IQT, Intel Capital
    Mueon Corporation is building a modular, exponential computing platform for AI and hyperscale data centers.
43. TwoStep Therapeutics (twosteptx.com) — Series A · $62.5M · Palo Alto, US. Investors: 2048 Ventures, Alexandria Venture Investments, Arcadia, GC&H Investments
    TwoStep Therapeutics is developing new targeted therapeutics for solid tumors.
44. Ultra (ultra.tech) — Series A · $62M · New York City, US. Investors: Framework Ventures, Next View Ventures, Y Combinator
    Practical, general-purpose robots for repetitive industrial tasks
45. Oyster Therapeutics (oystertherapeutics.com) — Series A · $60M · London, GB
    Oyster Therapeutics is developing an oral treatment for Alzheimer’s disease aimed at degrading tau protein in patients.
46. Poseidon Aerospace (poseidonaero.com) — Series A · $60M · Alameda, US. Investors: Draper Associates, Drover Ventures, G Squared, Hanwha Asset Management
    Poseidon Aerospace is building a cargo plane for the defense and regional commercial cargo markets.
47. SiranBio (siranbio.com) — Series A · $59.5M
    SiranBio is building novel siRNA therapeutics for the biotechnology sector.
48. RougeTx (rougetx.com) — Series A · $58M. Investors: Angelini Ventures, Aurea, BioGeneration Ventures, European Investment Bank
    RougeTx is building a potential once-daily oral treatment for hereditary hemorrhagic telangiectasia for patients with this rare bleeding disorder.
49. HyImpulse (hyimpulse.de) — Series A · $57.9M · Neuenstadt am Kocher, DE
    HyImpulse is building launch services for space missions.
50. Typewriter Therapeutics, Inc. (typewritertx.com) — Series A · $56M · Cambridge, US. Investors: AN Venture Partners, ANRI, Gemseki Fund, RA Capital Management
    Typewriter Therapeutics, Inc. is building safe, durable and re-dosable genetic medicines for patients with cancer, autoimmune diseases, and severe genetic diseases.
51. Fathom Therapeutics (fathomtx.com) — Series A · $55M · New York, US. Investors: Kos Biotechnology Partners, Sutter Hill Ventures
    Fathom Therapeutics is building a physics- and AI-powered drug discovery platform for discovering and developing next-generation small molecule medicines.
52. Tectora Therapeutics (tectoratx.com) — Series A · $55M · New York, US. Investors: New Enterprise Associates, RA Capital Management
    Tectora Therapeutics is developing differentiated oral medicines for immune mediated diseases for patients with significant unmet need.
53. Humble Robotics (humblerobotics.ai) — Series A · $51M · San Francisco, US. Investors: Eclipse, Energy Impact Partners, Obvious Ventures, RedBlue Capital
    Humble Robotics is building autonomous hauling solutions for logistics and transportation.
54. Caspian Therapeutics (caspiantherapeutics.com) — Series A · $50M
    Caspian Therapeutics is dedicated to developing, regulating, and commercializing products targeting diabetes and other cardiometabolic diseases.
55. Chubby Group (chubbygroup.com) — Series A · $50M · Los Angeles, US. Investors: Prysm Capital
    Chubby Group is building a vertically integrated restaurant and hospitality platform for delivering premium Asian-inspired dining experiences.
56. Conveo (conveo.ai) — Series A · $50M · New York, US. Investors: 6 Degrees Capital, Balderton Capital, DST Global, Visionaries
    Conveo is building an AI consumer intelligence platform for large enterprises to better understand their customers.
57. Fortaegis (fortaegis.com) — Series A · $50M · Amsterdam, NL. Investors: Prodrive Technologies, Serendipity Capital, TEL Venture Capital, TNO
    Fortaegis is building a full-stack security architecture that embeds security in silicon to provide hardware-rooted identity and trust across distributed computing systems for enterprises and governments.
58. Gallatin AI (gallatin.ai) — Series A · $50M · Washington, US. Investors: 8VC, Banter Capital, Moonshots Capital, Silent Ventures
    Gallatin AI is building AI-powered solutions to modernize military logistics for defense organizations.
59. GEN Restaurant Group Inc. (investor.genkoreanbbq.com) — Series A · $50M · Cerritos, US
    GEN Restaurant Group Inc. is focusing on consumer packaged goods and aims to expand its operations in the retail sector.
60. Nuance (dragon.nuance.com) — Series A · $50M · Seattle, US. Investors: Accel, Define Ventures, Lightspeed Venture Partners, NVentures
    Nuance is building multimodal AI models with stronger emotional understanding capabilities for diverse applications.
61. Nuance Labs (nuancelabs.ai) — Series A · $50M · Seattle, US. Investors: Lightspeed Venture Partners, Nvidia
    Nuance Labs is building innovative AI solutions for businesses and developers.
62. Raindrop (raindrop.ai) — Series A · $50M · San Francisco, US. Investors: CRV, Lightspeed Venture Partners, Y Combinator
    Sentry for AI Agents
63. Runware (runware.ai) — Series A · $50M · Romania, RO. Investors: Dawn Capital, Insight Partners, a16z Speedrun
    Runware is building a developer tool platform specializing in generating images, videos, and audio in real time for developers integrating media assets into their applications.
64. ai3Bio (ai3.bio) — Series A · $48M · Watertown, US. Investors: Cockrell Interests, Tanis Ventures, UPMC Enterprises, Ziff Capital Partners
    ai3Bio is developing in vivo therapies designed to selectively eliminate pathogenic Th17 cells in autoimmune disease.
65. Lightfield (trylightfield.ai) — Series A · $47M · San Francisco, US. Investors: Andreessen Horowitz
    AI that works for in-house legal teams
66. Sensible Biotechnologies (sensible.bio) — Series A · $47M · Oxford, GB. Investors: Y Combinator
    Unlocking the next generation of mRNA medicines
67. Light (poweredbylight.com) — Series A · $46M · Austin, US. Investors: Activate Capital, BoxGroup, Gigascale Capital, MCJ
    Light is building a power-company-as-API platform that enables any company to offer electricity to its customers, tailored to their specific needs.
68. Coherence Neuro (coherenceneuro.com) — Series A · $45M · Melbourne, AU. Investors: Blackbird Ventures, Founders Fund, OpenAI Startup Fund
    Coherence Neuro is developing brain implants that use electrical signals to track and treat cancer in real time for patients with brain cancer.
69. Edelbyte (edelbyte.io) — Series A · $45M · Tel Aviv, IL. Investors: Cerca Partners, Greenoaks, QP Ventures, Quiet Capital
    Edelbyte is building a data platform designed to handle massive volumes of information for Fortune 500 companies and other global organizations.
70. Hyphenate (hyphenate.ai) — Series A · $45M · New York, US. Investors: B Capital, BoldCap, Foundation Capital, Gaia Ventures
    Hyphenate is building an autonomous finance platform for the office of the chief financial officer.
71. TravelX (travelx.io) — Series A · $45M · Miami, US. Investors: Kaszek, Thayer Ventures
    TravelX is building an AI-native post-booking revenue management platform for airlines.
72. Anaheim Bio (anaheimbio.com) — Series A · $44.9M · Leiden, NL. Investors: Droia Ventures, Frazier Life Sciences, Novartis Venture Fund, RTW
    Anaheim Bio is building a small molecule therapeutic for calcium pyrophosphate deposition disease (CPPD) for patients suffering from this condition.
73. Adaptyv (adaptyvbio.com) — Series A · $44.7M · Lausanne, CH. Investors: Ace Ventures, byFounders, Highland Europe, Y Combinator
    Adaptyv is building an automated wet lab for AI-driven protein design for advancing drug discovery.
74. Deep Cogito (deepcogito.com) — Series A · $43M · San Francisco, US. Investors: Atreides Management, Benchmark, Nexus Venture Partners, South Park Commons
    Deep Cogito is building a post-training research platform for reinforcement learning, recursive self-improvement and enterprise AI specialization.
75. Kadig (kadig.com.br) — Series A · $43M · Los Angeles, US. Investors: Unnamed Brazilian bank
    Kadig is a Brazilian technology company focused on developing digital products, technology platforms and innovative solutions for international markets.
76. Pluto Security (pluto.security) — Series A · $42M. Investors: Ansa Capital, Jump Capital, Skinos Ventures, TLV Partners
    Pluto Security is building an AI-driven security platform to help enterprises manage risks associated with the use of AI tools by employees.
77. AIUC (aiuc.com) — Series A · $40M. Investors: First Harmonic, Ribbit Capital
    AIUC is building a third-party audit and certification layer for AI agents to ensure their security and compliance for enterprises.
78. Artificial Intelligence Underwriting Company (aiunderwriting.com) — Series A · $40M. Investors: Emergence Capital, First Harmonic, NFDG, Ribbit Capital
    Artificial Intelligence Underwriting Company is building a confidence infrastructure for AI agents to enable enterprises to adopt AI technology with confidence.
79. Artificial Intelligence Underwriting Company (AIUC) (linkedin.com) — Series A · $40M. Investors: First Harmonic, Ribbit Capital
    Artificial Intelligence Underwriting Company (AIUC) is building a third-party audit and certification system for AI agents for enterprises seeking standards in deploying AI technology.
80. Baba (callbaba.com) — Series A · $40M · New York City, US. Investors: CVS Health Ventures, FirstMark Capital, General Catalyst, Genius Ventures
    Baba is an applied AI company modernizing the Medicare and Medicaid experience for patients and families.
81. Bites (mybites.io) — Series A · $40M · Tel Aviv, IL. Investors: Horizon VC, Lyra Ventures, PeakSpan Capital, Rittenhouse Ventures
    Bites is building an AI-powered platform that enables companies to create personalized training materials for employees.
82. Quintessent (quintessent.com) — Series A · $40M · Santa Barbara, US. Investors: Ciena, Cycle Capital, Entrada Ventures, Foothill Ventures
    Quintessent is developing optical connectivity solutions to interconnect compute and switch chips with massively accelerated and power efficient bandwidth across the datacenter.
83. Quintessent Inc. (quintessent.com) — Series A · $40M
    Quintessent Inc. is building a single-chip comb laser for AI accelerator (xPU) chip makers.
84. Starget Pharma (stargetpharma.com) — Series A · $40M · Shreveport, US. Investors: BRF, Cancer Focus Fund, Ilex Medical Ltd, Louisiana Economic Development's Louisiana Growth Fund
    Starget Pharma is building innovative pharmaceutical solutions for the medical imaging and therapy sectors.
85. Wafer (wafer.ai) — Series A · $40M · San Francisco, US. Investors: AMD Ventures, Chemistry, Fifty Years, Marathon Venture Capital
    Wafer is developing technology designed to automate the process of optimizing AI inference deployments for AI infrastructure operators.
86. Braid (braid.com) — Series A · $38M · Amsterdam, NL. Investors: KPN Ventures, Octopus Ventures
    Braid is building an enterprise connectivity platform for businesses to integrate branded mobile connectivity into their services without becoming telecom operators.
87. doxx.net (doxx.net) — Series A · $38M. Investors: Andreessen Horowitz, ANIMO Ventures, Focal
    doxx.net is building a private network platform that allows users and their AI agents to create and operate private networks for enhanced privacy and control.
88. Orion (orioninc.com) — Series A · $38M · New York, US. Investors: IBM, Lama Partners, Norwest Venture Partners, PICO Venture Partners
    Orion is building a multi-agent AI platform designed to transform data analytics and decision-making processes for organizations.
89. Airbound (airbound.co) — Series A · $37M · Bengaluru, IN. Investors: DoorDash, Greenoaks, Humba Ventures, Lachy Groom
    Airbound is building delivery drones for transporting medical samples and other logistics.
90. Altay Therapeutics (altaytherapeutics.com) — Series A · $37M · San Francisco, US. Investors: Biogen New Ventures, Fountain Healthcare Partners, Global BioAccess Fund, HealthCap
    Altay develops disease-modifying therapies targeting transcription…
91. Andera (andera.ai) — Series A · $37M · San Francisco, US. Investors: Lightspeed Venture Partners
    Andera is building an automation solution for corporate audit and compliance tasks for businesses.
92. HIFI (hifi.com) — Series A · $37M · New York, US. Investors: Left Lane Capital
    HIFI is building a platform for tokenized markets for digital asset trading.
93. ReEmerge, Inc. (reemergeinc.com) — Series A · $37M · Minnesota, US. Investors: 415 Capital, Dendrion Ventures, IAG Capital Partners, Oxford Science Enterprises
    ReEmerge, Inc. is building an implantable deep brain stimulation system for chronic cognitive impairment following traumatic brain injury (TBI).
94. Aegis AI Security (aegisai.ai) — Series A · $36M
    Aegis AI Security is building autonomous AI agents to analyze emails and detect spear phishing and other attacks for businesses.
95. Luum (luumlash.com) — Series A · $36M · Dallas, US. Investors: Artifact Capital, Boardman Bay Capital Management, Long Journey Ventures
    Luum is building robotic technology for beauty services, focusing initially on automated eyelash extensions for consumers.
96. Redx Pharma (redxpharma.com) — Series A · $36M. Investors: Abingworth, Redmile Group
    Redx Pharma is building therapies focused on gastrointestinal diseases for patients suffering from Crohn’s disease.
97. Element One Hydrogen & Critical Minerals Corp. (e1-h2.com) — Series A · $35.5M. Investors: Mantle8
    Element One Hydrogen & Critical Minerals Corp. is building regional exploration capabilities for assessing natural hydrogen exploration prospects.
98. PeopleX (corp.peoplex.jp) — Series A · $35.2M · Tokyo, JP. Investors: Angel Bridge, En, One Capital, Open Up Group
    PeopleX is building an HR and sales-focused AI platform for organizations looking to automate and optimize their productivity.
99. Architect Financial Technologies (architect.exchange) — Series A · $35M. Investors: ARK Invesst, ARK Invest, CMT Digital, Coinbase Ventures
    Architect Financial Technologies is building a fintech infrastructure for financial institutions to handle trading and post-processing of traditional and digital asset classes.
100. EIT Pharma (eitpharma.com) — Series A · $35M · Kirkland, US. Investors: Arrowtown, Good Ventures, Propel Bio Partners
     EIT Pharma is a biotechnology company focused on developing therapies for infectious diseases for patients with significant unmet medical needs.

…and 259 more in the app.